Brokers' Take
Hyflux, June 15 closing : $1.46
16 June 2004
The
Business Times
G K Goh Research
HYFLUX plans to spend US$90 million on a seawater desalination
plant in the Chinese city of Tianjin. When completed in 2006, the
membrane-based plant, with a capacity of 100,000 cubic metres (m3)
a day, will be one of the biggest in China, supplying industrial
and city-grade water for an initial period of 30 years, with provision
for a subsequent extension. There are plans to expand the plant's
capacity to 150,000 m3 per day by 2008.
This is Hyflux's first municipal build-own-operate (BOO) project
in China and the biggest contract the company has secured.
But it's difficult to quantify the likely impact, as vital details
are pending until the end of next year.
There's a strong likelihood that equity partner(s) will be roped
in to reduce Hyflux's capex outlay.
A possible model would be for partners to set up a joint venture
company to take on the project and award the contract to Hyflux.
Based on this scenario, Hyflux could potentially triple its outstanding
order book to some $180 million for recognition over the next two
years.
Our FY05 forecast has already assumed contract wins. So this project
is unlikely to have a major impact, but it will improve earnings
visibility.
More BOO and build-operate-transfer (BOT) projects can be expected
as Hyflux strives to build its recurrent income base.
The group is tendering for Singapore's biggest Newater project
at Ulu Pandan. That tender will close in the third week of July,
bids will likely be unveiled a few weeks later and the contract
will be awarded possibly in September/October.
Besides Singapore and China, Hyflux is also reviewing BOO/BOT opportunities
in other Asian markets.
Compiled by VEN SREENIVASAN
|